Search of inhibitors of aldose reductase for treatment of diabetic cataracts using machine learning
Purpose: Patients with diabetes mellitus have an elevated chance of developing cataracts, a degenerative vision-impairing condition often needing surgery. The process of the reduction of glucose to sorbitol in the lens of the human eye that causes cataracts is managed by the Aldose Reductase Enzyme...
Main Authors: | Trevor Chen, Richard Chen, Alvin You, Valentina L. Kouznetsova, Igor F. Tsigelny |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Advances in Ophthalmology Practice and Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667376223000306 |
Similar Items
-
In Search of Differential Inhibitors of Aldose Reductase
by: Francesco Balestri, et al.
Published: (2022-03-01) -
Astragalin attenuates diabetic cataracts via inhibiting aldose reductase activity in rats
by: Na Wang, et al.
Published: (2023-08-01) -
The aldose reductase inhibitors AT-001, AT-003 and AT-007 attenuate human keratinocyte senescence
by: Gautham Yepuri, et al.
Published: (2024-12-01) -
Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat
by: Marjan Khorsand, et al.
Published: (2016-07-01) -
Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review
by: Alexandra-Ioana Dănilă, et al.
Published: (2024-03-01)